SCHEMBL13768243

SCHEMBL13768243

COc1cc(O)cc(Nc2ccnc3ccc(S(C)(=N)=O)cc23)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAK O14976 8/20 0.58
RIPK2 O43353 12/20 0.51
KDR P35968 3/20 0.51
RET P07949 1/20 0.51
MAPK14 Q16539 1/20 0.51
PKMYT1 Q99640 1/20 0.51
COQ8A Q8NI60 5/20 0.49
NLK Q9UBE8 5/20 0.49
RAF1 P04049 1/20 0.45
BRAF P15056 1/20 0.45
KCNH2 Q12809 3/20 0.44
EPHB6 O15197 1/20 0.43
STK16 O75716 1/20 0.43
ABL1 P00519 1/20 0.43
ACVR1 Q04771 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
PDGFRA P16234 1/20 0.43
PDE4B Q07343 1/20 0.43
RIPK1 Q13546 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13768384 0.89 GAK (0.55) GAKRIPK2KDRRETMAPK14
SCHEMBL13768244 0.87 GAK (0.53) GAKRIPK2KDRRETMAPK14
SCHEMBL13768249 0.86 GAK (0.52) GAKRIPK2KDRRETMAPK14
SCHEMBL13768388 0.84 GAK (0.48) GAKRIPK2KDRRETMAPK14
SCHEMBL2284234 0.83 GAK (0.49) GAKRIPK2KDRRETMAPK14
SCHEMBL2285466 0.83 GAK (0.48) GAKRIPK2KDRRETMAPK14
SCHEMBL13768081 0.83 RAF1 (0.52) GAKRIPK2KDRRETMAPK14
SCHEMBL13768651 0.82 RIPK2 (0.57) GAKRIPK2KDRRETMAPK14
SCHEMBL14035048 0.82 RIPK2 (0.56) GAKRIPK2KDRPKMYT1COQ8A
SCHEMBL2286179 0.82 GAK (0.48) GAKRIPK2KDRRETMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080200-A1 NOVEL SULPHOXIMIDE-SUBSTITUTED QUINOLINE AND QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed
EP-2072502-A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors Bayer Schering Pharma Aktiengesellschaft (DE) 2009-06-24 EP disclosed